Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By

  • Safely Prescribing Controlled Substances in Oncology
    Contains 13 Product(s)

    The Safely Prescribing Controlled Substances in Oncology modules by APSHO include 13 comprehensive, and self-paced modules, thoughtfully crafted to equip you with the knowledge and expertise necessary to safely prescribe controlled substances and to understand and manage substance use disorders in the hematology/oncology setting. 9 CE-Accredited Hours (3.5 pharmacology hours for ANCC accreditation)

    The Safely Prescribing Controlled Substances in Oncology modules by APSHO include 13 comprehensive, and self-paced modules, thoughtfully crafted to equip you with the knowledge and expertise necessary to safely prescribe controlled substances and to understand and manage substance use disorders in the hematology/oncology setting. (These modules will meet the DEA requirement for 8 hours of training on substance use disorder.)  9 CE-Accredited Hours (3.5 pharmacology hours for ANCC accreditation)

  • Diversity, Equity, and Inclusion in Oncology
    Contains 8 Product(s)

    The Diversity, Equity, and Inclusion in Oncology modules by APSHO include 8 comprehensive and self-paced modules to equip you with the understanding of health disparities, inequities and structural racism in the hematology/oncology setting and how these affect patient outcomes. (Additionally, one of the modules addresses health disparities and inequities in substance use disorders and this module meets the DEA requirement for training on substance use disorder.) 3.75 CE-Accredited Hours

    The Diversity, Equity, and Inclusion in Oncology modules by APSHO include 8 comprehensive and self-paced modules to equip you with the understanding of health disparities, inequities and structural racism in the hematology/oncology setting and how these affect patient outcomes. (Additionally, one of the modules addresses health disparities and inequities in substance use disorders and this module meets the DEA requirement for training on substance use disorder.) 3.75 CE-Accredited Hours

  • Healthcare Disparities in Lung Cancer
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Healthcare Disparities in Lung Cancer Medical PA 0.50 0.00
    CE Certificates: Healthcare Disparities in Lung Cancer Medical PharmD 0.50 0.00
    CE Certificates: Healthcare Disparities in Lung Cancer Medical NP/Nursing 0.50 0.00
    CE Certificates: Healthcare Disparities in Lung Cancer Medical Attendance (Other) 0.50 0.00

    0.50 CE-Accredited Hours

    • Articulate the impact of lung cancer health disparity in various populations 
    • Identify the disparities in lung cancer in screening, diagnosis, and treatment 
    • Describe the advanced practitioner role in lung cancer screening and the impact on racial and ethnic survival disparities

    Kristen O’Hagan

    MSN, RN, ANP-BC, AOCNP

    Memorial Sloan Kettering Cancer Center

    Kristen O’Hagan has no relevant financial relationships to disclose

    Lisania Milli

    MSN, RN, WHNP-BC

    Memorial Sloan Kettering Cancer Center

    Lisania Milli has no relevant financial relationships to disclose

  • Healthcare Disparities in Colorectal Cancer
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Healthcare Disparities in Colorectal Cancer Medical PA 0.50 0.00
    CE Certificates: Healthcare Disparities in Colorectal Cancer Medical PharmD 0.50 0.00
    CE Certificates: Healthcare Disparities in Colorectal Cancer Medical NP/Nursing 0.50 0.00
    CE Certificates: Healthcare Disparities in Colorectal Cancer Medical Attendance (Other) 0.50 0.00

    0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)

    • Articulate the impact of colorectal cancer (CRC) in Black individuals in terms of mortality
    • Identify the disparities in CRC in screening, diagnosis, and treatment
    • Describe the advanced practitioner role in screening and the impact on racial and ethnic survival disparities

    Lisania Milli

    MSN, RN, WHNP-BC

    Memorial Sloan Kettering Cancer Center

    Lisania Milli has no relevant financial relationships to disclose

    Kristen O’Hagan

    MSN, RN, ANP-BC, AOCNP

    Memorial Sloan Kettering Cancer Center

    Kristen O’Hagan has no relevant financial relationships to disclose

  • Healthcare Disparities in Breast Cancer
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Healthcare Disparities in Breast Cancer Medical PA 0.50 0.00
    CE Certificates: Healthcare Disparities in Breast Cancer Medical PharmD 0.50 0.00
    CE Certificates: Healthcare Disparities in Breast Cancer Medical NP/Nursing 0.50 0.00
    CE Certificates: Healthcare Disparities in Breast Cancer Medical Attendance (Other) 0.50 0.00

    0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)

    • Differentiate between health disparity versus health inequity
    • Discuss how race, ethnicity, and socioeconomic status contribute to breast cancer disparities 
    • Describe the impact of culture, implicit bias, and institutional racism on treatment outcomes and mortality 

    Rose Dimarco

    PharmD, BCPS, BCOP

    Jefferson Health’s Sidney Kimmel Cancer Center

    Dr. Rose DiMarco is an advanced clinical pharmacist of oncology at Jefferson Health’s Sidney Kimmel Cancer Center, specializing in breast and gynecologic cancer care. She presents at Jefferson’s Cancer Support Center to members of the community on topics such as Chemotherapy Side Effects, Targeted Therapy, Supportive Care Management, and Insomnia in Cancer, and is an Advanced Pharmacy Practice Experience preceptor for pharmacy students looking to gain education and training in oncology. Dr. DiMarco is a member of the Hematology/Oncology Pharmacy Association and serves on APSHO’s Diversity, Equity, and Inclusion Committee.

    Dr. DiMarco has the following relevant financial relationship to disclose:

    • Bristol Myers Squibb Advisory Board for Oncology – Immunotherapy

  • Confronting Structural Racism and Advancing Equity
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Confronting Structural Racism and Advancing Equity Medical PA 0.25 0.00
    CE Certificates: Confronting Structural Racism and Advancing Equity Medical PharmD 0.25 0.00
    CE Certificates: Confronting Structural Racism and Advancing Equity Medical NP/Nursing 0.25 0.00
    CE Certificates: Confronting Structural Racism and Advancing Equity Medical Attendance (Other) 0.25 0.00

    0.25 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)

    • Define racism and summarize its impact on patient care.
    • List different types of historical structural racism.
    • State the role of the AP in dismantling structural racism.

    F. Diane Barber

    PhD, ANP-BC, AOCNP, FAANP, FAAN

    Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) University of Texas MD Anderson Cancer Center

    F. Diane Barber has no relevant financial disclosures

  • Addressing Health Disparities in Substance Abuse in the Oncology Setting
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Addressing Health Disparities in Substance Abuse in the Oncology Setting Medical PA 0.75 0.00
    CE Certificates: Addressing Health Disparities in Substance Abuse in the Oncology Setting Medical PharmD 0.75 0.00
    CE Certificates: Addressing Health Disparities in Substance Abuse in the Oncology Setting Medical NP/Nursing 0.75 0.00
    CE Certificates: Addressing Health Disparities in Substance Abuse in the Oncology Setting Medical Attendance (Other) 0.75 0.00

    0.75 CE-Accredited Hours

    • Define substance use disorder (SUD) and describe health disparities related to this
    • List factors contributing to health disparities in SUD
    • Discuss the role of the advanced practitioner in addressing health disparities in the patient with SUD

    Wendy Vogel

    MSN, FNP, AOCNP, FAPO

    APSHO, Executive Director

    Wendy Vogel has no relevant financial relationships to disclose

    Cyndi Davis

    NP

    Cayuga Cancer Center

    Cyndi Davis has no relevant financial relationships to disclose

  • Mitigating the Stigma Associated With Substance Use Disorder in the Patient With Cancer
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Mitigating the Stigma Associated With Substance Use Disorder in the Patient With Cancer Medical PA 0.75 0.00
    CE Certificates: Mitigating the Stigma Associated With Substance Use Disorder in the Patient With Cancer Medical PharmD 0.75 0.00
    CE Certificates: Mitigating the Stigma Associated With Substance Use Disorder in the Patient With Cancer Medical NP/Nursing 0.75 0.00
    CE Certificates: Mitigating the Stigma Associated With Substance Use Disorder in the Patient With Cancer Medical Attendance (Other) 0.75 0.00

    0.75 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)

    • Define stigma and understand the history of stigma in substance use disorders (SUDs)
    • Understand contributing factors and the consequences of stigma in SUDs and how it relates to health outcomes with people with SUDs
    • Develop strategies for mitigating stigma in our communities and healthcare settings

    Vanessa Sanne

    RN, FNP-C, ACHPN

    Compass Oncology

    Vanessa Sanne has no relevant financial relationships to disclose.

  • Mitigating Risk for Substance Use Disorder in the Patient With Cancer
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Mitigating Risk for Substance Use Disorder in the Patient With Cancer Medical PA 0.50 0.00
    CE Certificates: Mitigating Risk for Substance Use Disorder in the Patient With Cancer Medical PharmD 0.50 0.00
    CE Certificates: Mitigating Risk for Substance Use Disorder in the Patient With Cancer Medical NP/Nursing 0.50 0.00
    CE Certificates: Mitigating Risk for Substance Use Disorder in the Patient With Cancer Medical Attendance (Other) 0.50 0.00

    0.50 CE-Accredited Hours (0.25 pharmacology hours for ANCC accreditation)

    • Recognize risk factors for substance use disorder and articulate examples
    • Describe the impact family history has as a risk factor for substance use disorders
    • Relate the concept of resilience as a protective measure against substance use disorder

    Gretchen A. McNally

    PhD, ANP-BC

    Arthur G. James Cancer Hospital, The Ohio State University

    Gretchen A. McNally has no relevant financial relationships to disclose.

  • Ethical and Legal Issues in Substance Use Disorders in Oncology
    Contains 5 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    CE Certificates: Ethical and Legal Issues in Substance Use Disorders in Oncology Medical PA 0.75 0.00
    CE Certificates: Ethical and Legal Issues in Substance Use Disorders in Oncology Medical PharmD 0.75 0.00
    CE Certificates: Ethical and Legal Issues in Substance Use Disorders in Oncology Medical NP/Nursing 0.75 0.00
    CE Certificates: Ethical and Legal Issues in Substance Use Disorders in Oncology Medical Attendance (Other) 0.75 0.00

    0.75 CE-Accredited Hours (0.50 pharmacology hours for ANCC accreditation)

    • Define the ethical and legal issues regarding patients with substance use disorders in oncology care
    • Describe the REMS process for prescribing select opioids
    • Illustrate legal and ethical implications for APs using a case-based approach

    Jeannine M. Brant

    PhD, APRN, AOCN, FAAN

    City of Hope

    Jeannine Brant has no relevant financial relationships to disclose.